Order Article Reprints

Sancho-López A, Ruiz-Antorán B, Hernangómez TI, Ramírez-García A, Gómez-Estévez I, Sanabria-Cabrera J, Llop Rius R, Pedrós C, Campodonico D, Jiménez-Jorge S, et al. The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study). Journal of Clinical Medicine. 2023; 12(20):6471. https://doi.org/10.3390/jcm12206471

Sancho-López, Arantxa, Belén Ruiz-Antorán, Teresa Iglesias Hernangómez, Almudena Ramírez-García, Irene Gómez-Estévez, Judith Sanabria-Cabrera, Roser Llop Rius, Consuelo Pedrós, Diana Campodonico, Silvia Jiménez-Jorge, and et al. 2023. "The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study)" Journal of Clinical Medicine 12, no. 20: 6471. https://doi.org/10.3390/jcm12206471

Sancho-López, A., Ruiz-Antorán, B., Hernangómez, T. I., Ramírez-García, A., Gómez-Estévez, I., Sanabria-Cabrera, J., Llop Rius, R., Pedrós, C., Campodonico, D., Jiménez-Jorge, S., García Luque, A., Costa Frossad França, L., Montané, E., Aldea-Perona, A., Téllez Lara, N., Bosch Ferrer, M., Rodriguez Jiménez, C., Bonilla-Toyos, E., Sabín Muñoz, J., ... , o. b. o. t. R.-S. G., on behalf of the REALHES-Study Group. (2023). The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study). Journal of Clinical Medicine, 12(20), 6471. https://doi.org/10.3390/jcm12206471